Journals / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 3

Catheter ablation for atrial fibrillation: a contemporary narrative review of indications, techniques, and emerging technologies

Güney Sarıoğlu(Malatya Battalgazi Devlet Hastanesi)0000-0002-1049-1873
Ertuğrul Kurtoğlu(MALATYA TURGUT ÖZAL ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-5835-087X
Pages
—
Publication Date
2026-05-22
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Advances in technology and personalised strategies are expected to improve effectiveness and reduce risks.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This review summarises the current indications for catheter ablation in the treatment of atrial fibrillation (AF), its fundamental technical principles, and new technologies.
📊
Key Findings & Data:The effects of rhythm control, which is superior to drug therapy in symptomatic paroxysmal and persistent AF, reduction in AF burden, and potential mortality/functional improvement are discussed; the fundamental role of pulmonary vein isolation, additional substrate ablation strategies in persistent AF, special considerations in patients with concomitant Structural heart disease (SHD) and heart failure, and new energies such as pulsed field ablation are evaluated.
💡
Conclusion & Impact:Advances in technology and personalised strategies are expected to improve effectiveness and reduce risks.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Catheter ablation · pulmonary veins · cryoablation

Abstract

This review summarises the current indications for catheter ablation in the treatment of atrial fibrillation (AF), its fundamental technical principles, and new technologies. The effects of rhythm control, which is superior to drug therapy in symptomatic paroxysmal and persistent AF, reduction in AF burden, and potential mortality/functional improvement are discussed; the fundamental role of pulmonary vein isolation, additional substrate ablation strategies in persistent AF, special considerations in patients with concomitant Structural heart disease (SHD) and heart failure, and new energies such as pulsed field ablation are evaluated. AF catheter ablation, performed in suitable patients, with optimal timing and in experienced centres, is a key part of modern AF management. It greatly improves symptoms and can positively affect prognosis in some groups. Advances in technology and personalised strategies are expected to improve effectiveness and reduce risks.

🔖

Cite This Article

Sarıoğlu, G., Kurtoğlu, E. (2026). Catheter ablation for atrial fibrillation: a contemporary narrative review of indications, techniques, and emerging technologies. Anatolian Current Medical Journal, Volume: 8 Issue: 3. https://doi.org/10.38053/acmj.1896183

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (48)

  1. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453-1468. doi:10.1161/CIRCRESAHA.114.303211
  2. Willems S, Wegner F, Eckardt L. Atrial fibrillation guideline group. clinical practice guideline: preventive measures and treatment options for atrial fibrillation. Dtsch Arztebl Int. 2025;122(16):439-444. doi:10. 3238/arztebl.m2025.0082
  3. Sagris M, Vardas EP, Theofilis P, Antonopoulos AS, Oikonomou E, Tousoulis D. Atrial fibrillation: pathogenesis, predisposing factors, and genetics. Int J Mol Sci. 2021;23(1):6. doi:10.3390/ijms23010006
  4. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217-221. doi:10.1177/1747493019897870
  5. Elliott AD, Middeldorp ME, Van Gelder IC, Albert CM, Sanders P. Epidemiology and modifiable risk factors for atrial fibrillation. Nat Rev Cardiol. 2023;20(6):404-417. doi:10.1038/s41569-022-00820-8
  6. Deshmukh A, Covassin N, Dauvilliers Y, Somers VK. Sleep disruption and atrial fibrillation: evidence, mechanisms and clinical implications. Circ Res. 2025;137(5):788-808. doi:10.1161/CIRCRESAHA.125.325612
  7. Tzeis S, Gerstenfeld EP, Kalman J, et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2024;26(4): euae043. doi:10.1093/europace/euae043
  8. AlTurki A, Essebag V. Atrial fibrillation ablation: impact on burden and cardiovascular outcomes. J Clin Med. 2025;14(8):2648. doi:10.3390/jcm14082648
  9. Kowalewski M, Dąbrowski EJ, Kurasz A, et al. Surgical ablation of atrial fibrillation with concomitant cardiac surgery: a state-of-the-art review. Eur J Cardiothorac Surg. 2025;67(7):ezaf187. doi:10.1093/ejcts/ezaf187
  10. Andrade JG, Champagne J, Dubuc M, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation. 2019;140(22):1779-1788. doi:10.1161/CIRCULATIONAHA.119.042622
  11. Brundel BJJM, Ai X, Hills MT, Kuipers MF, Lip GYH, de Groot NMS. Atrial fibrillation. Nat Rev Dis Primers. 2022;8(1):21. doi:10.1038/s41572-022-00347-9
  12. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91(1):265-325. doi:10.1152/physrev.00031.2009
  13. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54(2):230-246. doi:10.1016/s0008-6363(02)00258-4
  14. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66(8):943-959. doi:10.1016/j.jacc.2015.06.1313
  15. Horrach CV, Bevis L, Nwanna C, et al. Atrial fibrosis in atrial fibrillation: Mechanisms, mapping techniques and clinical applications. J Physiol. 2025. doi:10.1113/JP288680
  16. Boersma L, Andrade JG, Betts T, et al. Progress in atrial fibrillation ablation during 25 years of Europace journal. Europace. 2023;25(9): euad244. doi:10.1093/europace/euad244
  17. Parameswaran R, Al-Kaisey AM, Kalman JM. Catheter ablation for atrial fibrillation: current indications and evolving technologies. Nat Rev Cardiol. 2021;18(3):210-225. doi:10.1038/s41569-020-00451-x
  18. Sørensen SK, Johannessen A, Worck R, Hansen ML, Hansen J. Radiofrequency versus cryoballoon catheter ablation for paroxysmal atrial fibrillation: durability of pulmonary vein isolation and effect on atrial fibrillation burden: the RACE-AF randomized controlled trial. Circ Arrhythm Electrophysiol. 2021;14(5):e009573. doi:10.1161/CIRCEP. 120.009573
  19. Quintanilla JG, Shpun S, Jalife J, Filgueiras-Rama D. Novel approaches to mechanism-based atrial fibrillation ablation. Cardiovasc Res. 2021; 117(7):1662-1681. doi:10.1093/cvr/cvab108
  20. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812-1822. doi: 10.1056/NEJMoa1408288
  21. Reddy VY, Neuzil P, Koruth JS, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol. 2019;74(3):315-326. doi:10.1016/j.jacc.2019.04.021
  22. Reddy VY, Calkins H, Mansour M, et al. Pulsed field ablation to treat paroxysmal atrial fibrillation: safety and effectiveness in the AdmIRE pivotal trial. Circulation. 2024;150(15):1174-1186. doi:10.1161/CIRCULATIONAHA.124.070333
  23. Chun KJ, Miklavčič D, Vlachos K, et al. State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective. Europace. 2024;26(6):euae134. doi:10.1093/europace/euae134
  24. Vlachakis PK, Theofilis P, Apostolos A, et al. Beyond pulmonary vein reconnection: exploring the dynamic pathophysiology of atrial fibrillation recurrence after catheter ablation. J Clin Med. 2025;14(9): 2919. doi:10.3390/jcm14092919
  25. Ioannou A, Papageorgiou N, Lim WY, et al. Efficacy and safety of ablation index-guided catheter ablation for atrial fibrillation: an updated meta-analysis. Europace. 2020;22(11):1659-1671. doi:10.1093/europace/euaa224
  26. Osorio J, Miranda-Arboleda AF, Velasco A, et al. Real-world data of radiofrequency catheter ablation in paroxysmal atrial fibrillation: Short- and long-term clinical outcomes from the prospective multicenter REAL-AF Registry. Heart Rhythm. 2024;21(11):2083-2091. doi:10.1016/j.hrthm.2024.04.090
  27. Kuck KH, Brugada J, Fürnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23): 2235-2245. doi:10.1056/NEJMoa1602014
  28. Della Rocca DG, Marcon L, Magnocavallo M, et al. Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison. Europace. 2023;26(1): euae016. doi:10.1093/europace/euae016
  29. Reddy VY, Gerstenfeld EP, Natale A, et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med. 2023; 389(18):1660-1671. doi:10.1056/NEJMoa2307291
  30. Calvert P, Mills MT, Xydis P, et al. Cost, efficiency, and outcomes of pulsed field ablation vs thermal ablation for atrial fibrillation: a real-world study. Heart Rhythm. 2024;21(9):1537-1544. doi:10.1016/j.hrthm. 2024.05.032
  31. Martins Esteves I, de Pontes VB, Trevisan T, Jaramillo S, Gomes WF. Pulsed-field ablation versus radiofrequency ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis. J Arrhythm. 2025;41(4):e70158. doi:10.1002/joa3.70158
  32. Deepan N, Sripusanapan A, Prasitlumkum N, et al. Comparing efficacy and safety between pulsed field ablation, cryoballoon ablation and high-power short duration radiofrequency ablation in atrial fibrillation: a systematic review and network meta-analysis. J Interv Card Electrophysiol. 2025;68(5):1053-1063. doi:10.1007/s10840-025-02033-8
  33. Kirchhof P, Calkins H. Catheter ablation in patients with persistent atrial fibrillation. Eur Heart J. 2017;38(1):20-26. doi:10.1093/eurheartj/ehw260
  34. Hu X, Biase LD, Hou X, Liu X. Persistent atrial fibrillation ablation: glimpsing the light ahead? Europace. 2025;27(6):euaf037. doi:10.1093/europace/euaf037
  35. Reddy VY, Morales G, Ahmed H, et al. Catheter ablation of atrial fibrillation without the use of fluoroscopy. Heart Rhythm. 2010;7(11): 1644-1653. doi:10.1016/j.hrthm.2010.07.011
  36. Bohnen M, Minners J, Eichenlaub M, et al. Feasibility and safety of a three-dimensional anatomic map-guided transseptal puncture for left-sided catheter ablation procedures. Europace. 2023;25(3):1126-1134. doi: 10.1093/europace/euac262
  37. Di Biase L, Burkhardt JD, Mohanty P, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121(23): 2550-2556. doi:10.1161/CIRCULATIONAHA.109.921320
  38. Cardoso R, Knijnik L, Bhonsale A, et al. An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation. Heart Rhythm. 2018;15(1):107-115. doi:10.1016/j.hrthm.2017.09.011
  39. Nakamura K, Naito S, Sasaki T, et al. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events. Europace. 2019;21(2):259-267. doi:10.1093/europace/euy148
  40. Yamamoto T, Miyazaki S, Tanaka Y, et al. Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease-atrial fibrillation ablation registry. Europace. 2023;25(4):1400-1407. doi:10.1093/europace/euad056
  41. du Fay de Lavallaz J, Badertscher P, Ghannam M, et al. Severe periprocedural complications after ablation for atrial fibrillation: an international collaborative individual patient data registry. JACC Clin Electrophysiol. 2024;10(7 Pt 1):1353-1364. doi:10.1016/j.jacep.2024.03.024
  42. Guan F, Gass M, Berger F, Akdis D, Duru F, Wolber T. Transseptal puncture guided by three-dimensional electroanatomical mapping: early experience using a simplified approach in adults with congenital heart disease. J Clin Med. 2023;12(13):4491. doi:10.3390/jcm12134491
  43. Brasca FMA, Menè R, Perego GB. Catheter ablation for atrial fibrillation in structural heart disease: a review. J Clin Med. 2023;12(4):1431. doi:10. 3390/jcm12041431
  44. Packer DL, Piccini JP, Monahan KH, et al. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation. 2021;143(14):1377-1390. doi:10.1161/CIRCULATIONAHA.120.050991
  45. Assaf A, Feng H, Bsoul M, et al. Characterization of arrhythmia-induced cardiomyopathy using magnetic resonance imaging in patients with persistent atrial fibrillation and left ventricular systolic dysfunction-insights from DECAAF II. Eur J Heart Fail. 2025;27(9):1622-1632. doi: 10.1002/ejhf.3684
  46. Mistrulli R, Ferrera A, Muthukkattil ML, et al. Atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac amyloidosis: from clinical management to catheter ablation indication. J Clin Med. 2024;13(2):501. doi:10.3390/jcm13020501
  47. Ekanem E, Neuzil P, Reichlin T, et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med. 2024;30(7):2020-2029. doi:10.1038/s41591-024-03114-3
  48. Wyler von Ballmoos MC, Hui DS, Mehaffey JH, et al. The Society of Thoracic Surgeons 2023 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg. 2024;118(2):291-310. doi:10.1016/j.athoracsur.2024.01.007